Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.

Advanced Cardiovascular Systems, Inc. develops and manufactures cardiovascular medical products. It operates as a subsidiary of Abbott Laboratories. Its medical devices help patients with heart diseases in returning to active and productive lives and physicians for improving patient management and clinical outcomes. Advanced Cardiovascular Systems, Inc. is based in Santa Clara, California. it is currently known as Abbott Cardiovascular Systems.

Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN.

St. Jude Medical, Inc. was an American global medical device company headquartered in Little Canada, Minnesota, U.S., a suburb of Saint Paul. The company had more than 20 principal operations and manufacturing facilities worldwide with products sold in more than 100 countries. Its major markets include the United States, Europe, Latin America and Asia-Pacific. The company was named after Jude the Apostle, the patron saint of lost causes.

Medtronic Vascular designs and develops technologies for coronary, peripheral, and neurovascular indications. The company’s products include S7 Zipper MX Coronary Stent System, Clo-Sur PAD Nonwoven Hydrophilic Wound Dressing, Launcher Coronary Guide Catheter, and Stormer Over-the-Wire Balloon Dilatation Catheter. The company also offers Bridge Assurant Balloon-Expandable Stent Delivery System, GuardWire Plus Temporary Occlusion and Aspiration System, and S660 Coronary Stent. Medtronic Vascular was incorporated in 1991 and is based in Santa Rosa, California. As of January 29, 1999, Medtronic Vascular operates as a subsidiary of Medtronic.

Acorn Cardiovascular, Inc., a medical device company, develops treatments for patients with heart failure. Its product includes CorCap cardiac support device, a mesh warp that is implanted around the heart to provide ventricular support and reduce ventricular wall stress in patients with dilated cardiomyopathy and symptomatic heart failure. The company was incorporated in 1996 and is based in St. Paul, Minnesota.

Ouroboros Medical, Inc. provides medical devices for the treatment of spine diseases. The company was founded in 2007 and is headquartered in Pleasanton, CA.

Traverse Partners LLC, a subsidiary of Hovnanian Enterprises, Inc., is a company headquartered in Mooresville, NC. The firm provides investment advice. It was founded by Jeff Janer.

Ablative Solutions is a medical device firm that offers an alternative to surgical renal denervation for treating hypertension. Its technology involves endovascular catheters to provide an efficacious, durable, cost-effective, and safe alternative to surgical renal denervation for the treatment of hypertension and other diseases caused by an overactive sympathetic nervous system.

Boston Scientific Scimed, Inc. develops, manufactures, and markets medical devices used principally to treat cardiovascular disease.

Mardil Medical is a medical device company, develops therapies for structural heart diseases. It offers therapies for abnormalities in the shape of the heart muscle or valves. The company provides VenTouch, a targeted ventricular reshaping system that addresses the root cause of functional mitral valve regurgitation. Its VenTouch system is a conforming jacket that surrounds the heart’s pumping chambers and normalizes their shape with anatomy correcting the adjustability feature. Mardil Medical was incorporated in 2001 and is headquartered in Plymouth, Minnesota.

Incept is an effective vehicle for promotion and advancement of technology innovation and entrepreneurship with a primary focus in the life-sciences space, and occasional involvement in unique and select information-technology opportunities, where Incept’s management and financing depth is found to be transferable to the IT space. Incept’s mission is to innovate leadership product lines, meeting the important unmet technological needs of the medical technology space while cultivating leaders who build superb companies focused on growth and creation of shareholder value.

Heart Repair Technologies is a leader in the development of innovative products for cardiovascular medicine.

KeraVision engages in the development of a new category of non-laser vision correction products for the treatment of common vision disorders, including myopia, hyperopia, and astigmatism, to offer an alternative to eyeglasses, contact lenses, and other vision correction surgical procedures. Its first product, intacs corneal ring segments, has been approved by the FDA for correcting mild myopia in the range of -1.0 to -3.0 diopters in patients who are 21 years of age or older, who have a stable refraction, and who have up to +1.0 diopter of astigmatism. It is currently conducting a Phase III clinical trial to expand its approved range of indication for myopia to include -0.75 to -1.0 diopter and -3.1 to -4.5 diopters.

On-X Life Technologies develops, manufactures, and offers artificial heart valve replacement and repair products. The company’s product portfolio includes Aortic Heart Valve with Standard Sewing Ring, Aortic Heart Valve with Conform-X Sewing Ring, Aortic Heart Valve with Anatomic Sewing Ring, Mitral Heart Valve with Standard Sewing Ring, Mitral Heart Valve with Conform-X Sewing Ring, Ascending Aortic Prosthesis, Chord-XTM ePTFE Suture, CO2 diffusion catheters, and more. On-X Life Technologies was incorporated in 1994 and is based in Austin, Texas.

3F Therapeutics develops, manufactures, and markets cardiovascular devices. It offers invasive and transapical aortic heart replacement technology, including enabling aortic heart valve, entrata aortic valve system, and endurance valve system to reduce surgical cross-clamp and cardio-pulmonary bypass time, utilization for congestive heart failure.

Cordis Corp. develops and manufactures devices for interventional vascular medicine and electrophysiology. The firm's products include guidewires, balloons, forceps, catheters, and stents to treat a variety of circulatory system problems including coronary artery disease and cerebral aneurysms. The company was founded by William P. Murphy Jr. in 1959 and is headquartered in Milpitas, CA.

Arthrex GmbH, a subsidiary of Arthrex, Inc., is a German company located in Munich that manufactures orthopedic devices. Stefan Krupp is currently the CEO of the firm.